Primary Site >> Colorectal Cancer

Gene >> BIRC3

  • 1998
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
PMID: 9916987
Ref: Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2.
PMID: 12837940
Ref: Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis.
PMID: 14708638
Ref: Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK.
PMID: 15078890
Ref: Expression of IAP family proteins in colon cancers from patients with different age groups.
PMID: 15138717
Ref: Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit.
PMID: 15161687
Ref: Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.
PMID: 16061861
Ref: Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.
PMID: 16118352
Ref: Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo.
PMID: 17610066
Ref: Clearing the TRAIL for Cancer Therapy.
PMID: 17613431
Ref: Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
PMID: 17982676
Ref: The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.
PMID: 17704804
Ref: Targeting apoptosis as an approach for gastrointestinal cancer therapy.
PMID: 19278896
Ref: Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells.
PMID: 19302291
Ref: cIAP2 as a therapeutic target in colorectal cancer and other malignancies.
PMID: 19793002
Ref: Antiproliferative effect of chitosan-added kimchi in HT-29 human colon carcinoma cells.
PMID: 20136430
Ref: Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors.
PMID: 20682650
Ref: Nuclear factor kappa-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy.
PMID: 20630669
Ref: Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer.
PMID: 21264751
Ref: Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.
PMID: 21372226
Ref: Concomitant activation of caspase-9 and down-regulation of IAP proteins as a mechanism of apoptotic death in HepG2, T47D and HCT-116 cells upon exposure to a derivative from 4-aryl-4H-chromenes family.
PMID: 21565459
Ref: An apoptosis-independent role of SMAC in tumor suppression.
PMID: 22751125
Ref: Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.
PMID: 23388545
Ref: A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells.
PMID: 24170545
Ref: Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NFkappaB.
PMID: 24173769
Ref: The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
PMID: 24577083
Ref: Variable NF-kappaB pathway responses in colon cancer cells treated with chemotherapeutic drugs.
PMID: 25134433
Ref: EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells.
PMID: 25198428
Ref: Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects.
PMID: 24802097
Ref: High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.
PMID: 26071313
Ref: The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis.
PMID: 26383618
Ref: A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.
PMID: 26590805
Ref: Microarray Analysis of Gene Expression at the Tumor Front of Colon Cancer.
PMID: 26637872
Ref: A critical role for cellular inhibitor of protein 2 (cIAP2) in colitis-associated colorectal cancer and intestinal homeostasis mediated by the inflammasome and survival pathways.
PMID: 26037070
Ref: Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
PMID: 27171439
Ref: [Roles of glucose-regulated protein 78 in proliferation and migration of human colorectal carcinoma cell line RKO].
PMID: 27256049
Ref: Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer.
PMID: 27827395
Ref: Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.
PMID: 27889570
Ref: Evaluation of the Expression of the Inhibitor of Apoptosis Protein Family and Human Telomerase Reverse Transcriptase in Patients With Advanced Colorectal Adenoma.
PMID: 28698863
Ref: Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-kappaB signaling pathways.
PMID: 29689497
Ref: Transcriptomic analysis reveals the underlying pro-malignant functions of Gankyrin for colorectal cancer via affecting tumor necrosis factor pathway.
PMID: 29883699
Ref: Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
PMID: 29956753